PuraCath Medical has a platform of disinfection devices to help reduce catheter-related infections that occur due to airborne and touch contamination. With its first pioneering FDA cleared device in peritoneal dialysis (PD), PuraCath will improve the quality of life for the dialysis patient by reducing peritonitis infections and reducing the need for patient compliance to rigorous disinfection protocols by saving time through improved, simplified connections of PD catheters. Our novel, easy-to-use technology provides a safe treatment for patients on PD.  PuraCath is also expanding its product line to support vascular access catheters as well.


Julia Rasooly

Founder, CEO

John Ashley